10 results · 25ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

THE NEW BIO-MOORE ENDO HEADS

FDA 510(k)
FDA Class 2 ·Orthopedic

Polystar HK

FDA UDI
Merz Dental GmbH·D7091984028·anteriors; shade A1; mould R 88

PROCARE

FDA UDI
DJO, LLC·00190446660347·ARM SLING, CTN/POLY XLG

MULTI CAMERA CONTROL UNIT (MCCU)

FDA 510(k)
FDA Class 2 ·Radiology

AMBULATORY INFUSION SYSTEM AND ACCESSORIES

FDA 510(k)
FDA Class 2 ·General Hospital

BURN AID

FDA Adverse Event
Malfunction ·RYE PHARMACEUTICALS PTY. LTD.·Product code MGQ·April 18, 2000

PARADIGM REAL-TIME INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·MEDTRONIC MINIMED·Product code OYC·February 28, 2013

INTRACORPORAL LITHOTRIPTOR

FDA Adverse Event
Injury ·E.M.S. ELECTRO MEDICAL SYSTEMS S.A.·Product code FFK·February 4, 2011

EMAX 2 PLUS MOTOR

FDA Adverse Event
Malfunction ·DEPUY SYNTHES POWER TOOLS·Product code HBC·December 18, 2013

Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·October 25, 2017